Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Patheon |
U.S.A |
Patheon Italia S.p.A. | 68225-240 | Vedolizumab | 2014-05-20 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/5mL) |
| 28/03/2025 | Takeda Pharmaceutical |
Japan |
Takeda Pharmaceutical Company Limited | 11532-3002 | VEDOLIZUMAB | 2014-05-20 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/1) |
